Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 100

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 100
---
Incorporation by Reference The Organization & Compensation Committee Report and the Audit Committee Report (including the reference to the independence and financial expertise of the Audit Committee members), each contained in this proxy statement, are not deemed filed with the SEC and shall not be deemed incorporated by reference into any prior or future filings made by Humana under the Securities Act of 1933, except to the extent that we specifically incorporate such information by reference into any of these future filings. Additional Information Our Annual Report on Form 10-Kfor the year ended December 31, 2024, excluding certain of its exhibits, is included with the transmittal of this proxy statement. We will provide a copy without charge to anyone who makes a written request to Humana Inc., Investor Relations Department, 500 West Main Street, Louisville, KY 40202. Our Annual Report on Form 10-Kand all other filings with the SEC may also be accessed via the Investor Relations page on our website at www.humana.com. From the www.humana.comwebsite, click on “More Humana,” then click on “For Investors,” then click on “SEC Filings and Financial Reports,” and then click on “SEC Filings.” By Order of the Board of Directors, Joseph M. Ruschell Vice President, Associate General Counsel & Corporate Secretary

| 94 |     | Humana | 2025 Proxy Statement • Incorporation by Reference |

Annex I Reconciliation of Non-GAAPFinancial Measure We have included an Adjusted EPS financial measure (not in accordance with Generally Accepted Accounting Principles (GAAP)) in our proxy statement as we believe that this measure, when presented in conjunction with the corresponding GAAP measure, provides a comprehensive perspective to more accurately compare and analyze our core operating performance over time. Consequently, management uses this non-GAAP(Adjusted) financial measure as a consistent and uniform indicator of the Company’s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. The non-GAAP(Adjusted) financial measure should be considered in addition to, but not as a substitute for, or superior to, the financial measure prepared in accordance with GAAP. We encourage each stockholder to read the full financial analysis for year ended December 31, 2024 contained in our Annual Report on Form 10-K,filed with the SEC on February 20, 2025.

| Diluted Earnings Per Common Share (EPS) (